Pharma's Almanac

4358 Articles Available

1 182

Partnership

Novavax Selects AGC Biologics to Manufacture Matrix-M Adjuvant for Novel COVID-19 Vaccine

PR-M06-20-NI-008

Athira Pharma Closes $85 Million Series B Financing

PR-M06-20-NI-007

Collaboration

AstraZeneca to Discover and Develop Novel Therapies Targeting RNA-Modifying Proteins in Oncology Collaboration with Accent Therapeutics

PR-M06-20-NI-005

Leadership

Spectrum Pharmaceuticals Appoints Lyndah K. Dreiling, M.D., MBA, as Senior Vice President, Clinical Development

PR-M06-20-NI-006

Clinical Trials

Sun Pharma Receives Approval from DCGI to Initiate Clinical Trial with Nafamostat in Covid-19 Patients

PR-M06-20-NI-004

Financing

Hillhouse Capital Leads $160M Series B Round in Genor Biopharma

PR-M06-20-NI-003

Emergency Use Authorization

FDA Issues Emergency Use Authorization for Impella RP as Therapy for COVID-19 Patients with Right Heart Failure

PR-M06-20-NI-002

Investment

Pfizer Establishes New Program to Support Continued Biotechnology Innovation

PR-M06-20-NI-001

COVID-19

Montefiore-Einstein Scientists Lead Two Trials of Leronlimab for COVID-19

PR-M05-20-NI-045

Oncology

AstraZeneca Collaborates with ArcherDX to Use Personalized Cancer Assays to Detect Minimal Residual Disease in Lung Cancer Trials

PR-M05-20-NI-044

COVID-19 Vaccine

Novavax Expands Large-Scale Global Manufacturing Capacity for COVID-19 Vaccine

PR-M05-20-NI-043

COVID Vaccine

AAVCOVID Vaccine Program from Mass. Eye and Ear and Mass General Enters Manufacturing Agreement with Gene Therapy Leader AveXis, a Novartis Company

PR-M05-20-NI-042

Partnership

Gilead Sciences and Arcus Biosciences Establish 10-year Partnership to Co-develop and Co-commercialize Next-generation Cancer Immunotherapies

PR-M05-20-NI-041

Partnership

Thermo Fisher Scientific and CSL Enter Strategic Partnership

PR-M05-20-NI-040

Award

Vetter Wins Axia Best Managed Companies Award

PR-M05-20-NI-039

Collaboration

Rentschler Biopharma Extends Collaboration with Genmab to U.S. Facility

PR-M05-20-NI-038

BioMed X Institute Launches Rapid Antiviral Response Platform to Prevent Future Pandemics

PR-M05-20-NI-037

FDA Antibody Tests

FDA Provides Promised Transparency for Antibody Tests

COVID-19 Vaccine

IAVI and Merck Collaborate to Develop Vaccine Against SARS-CoV-2

PR-M05-20-NI-036

M&A

Merck to Acquire Themis

PR-M05-20-NI-035

Clinical Trials

Philips Launches HealthSuite Clinical Trial Accelerator

PR-M05-20-NI-034

COVID-19 Antibody Testing

Roche's Highly Accurate Antibody Test for COVID-19 Goes Live at More than 20 Initial Lab Sites in the U.S.

PR-M05-20-NI-035

HIV

ViiV Healthcare’s Injectable Formulation Dosed Every Two Months Shows Higher Efficacy than Daily Oral PrEP

PR-M05-20-NI-034

COVID-19 Vaccine

AstraZeneca Advances Response to COVID-19 After Receiving First Commitments for Oxford’s Potential New Vaccine

PR-M05-20-NI-033

1 182

»